Skip to content

Septerna, Inc. SEPN Free cash flow margin

Free cash flow margin at other companies

Amgen logo
AmgenAMGN
23.1%-8.9pp
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
36.2%+18.4pp
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-378.7%+24.1pp
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
5.8%+1.7pp
Precigen logo
PrecigenPGEN
-1,756.5%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
34.9%-15.2pp

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.65B+319%
Enterprise value$1.6B+1,325%
P/S22.8×-379×

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Calculated from Septerna, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Septerna, Inc.’s 10-Q, filed November 10, 2025, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s free cash flow margin?
Septerna, Inc. (SEPN) reported free cash flow margin of 467.9% in Q3 2025.
How has Septerna, Inc.'s free cash flow margin changed year-over-year?
Septerna, Inc.'s free cash flow margin increased by 107.9% year-over-year, from -5,916.3% to 467.9%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.